Loading…
Loading…
BIO · NYSE · Healthcare
“While others chase flashy biotech stories, this boring toolmaker quietly compounds wealth by selling picks and shovels to gold rush participants at reasonable prices.”
— In the voice of Munger
Side-by-side comparison of key financial metrics between two stocks to identify the better value opportunity.
Market Cap
$7.23B
P/E Ratio
9.51
Forward P/E
—
EPS
$27.87
PEG Ratio
-0.05
Book Value
$273.40
Dividend Yield
—
Profit Margin
29.42%
ROE
10.20%
Use the interactive stock comparison with pre-loaded data for Bio-Rad Laboratories Inc - Class A. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for BIO: